Compare McKesson Corporation (MCK) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Packaging Corporation of America — how do they compare? McKesson Corporation trades at $825.01 (market cap $97.35B), while Packaging Corporation of America trades at $228.77 (market cap $20.77B). The key difference: McKesson Corporation is far larger — about 4.7× Packaging Corporation of America's market cap, and Packaging Corporation of America pays the higher dividend (2.57%). Which is the better fit depends on your goals.
| MCK | PKG | |
|---|---|---|
Market Cap | $97.35B | $20.77B |
Sector | Health | Technology |
52-Week High | $995.69 | $246.31 |
52-Week Low | $659.01 | $191.41 |
Enterprise Value | $101.98B | $24.59B |
Dividend Yield | 0.39% | 2.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Packaging Corporation of America (PKG) trades at $228.43, down 1.99% today, with mixed technical signals showing bullish moving averages but neutral oscillators. The company reported Q1 2026 EPS of $2.40, beating estimates, but faces margin pressure with net income expected to decline to $741 million in 2026. Recent developments include a 20% dividend increase and upcoming Q2 earnings on July 22, 2026.
PKG presents a balanced outlook with strong institutional support and dividend growth offset by earnings volatility and margin compression. The consensus price target of $256.14 suggests 12% upside potential, but investors should monitor Q2 results and cost management amid inflationary pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
